ReviewSeminars in cancer biology2021
Repurposing old drugs as new inhibitors of the ubiquitin-proteasome pathway for cancer treatment.
Huanjie Yang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
40 papers cite it
this papercites it